These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15959653)

  • 61. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
    Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
    Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands.
    van Rij MC; de Die-Smulders CE; Bijlsma EK; de Wert GM; Geraedts JP; Roos RA; Tibben A
    Clin Genet; 2013 Feb; 83(2):118-24. PubMed ID: 23137131
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The expressivist objection to prenatal testing: the experiences of families living with genetic disease.
    Boardman FK
    Soc Sci Med; 2014 Apr; 107():18-25. PubMed ID: 24602967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of genetic testing for Huntington disease on the family system.
    Sobel SK; Cowan DB
    Am J Med Genet; 2000 Jan; 90(1):49-59. PubMed ID: 10602118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Huntington chorea: perspective changes in presymptomatic diagnosis (updating synthetic review)].
    Borri G
    Riv Neurol; 1989; 59(6):223-8. PubMed ID: 2534779
    [TBL] [Abstract][Full Text] [Related]  

  • 66. (Mis)alignments in counseling for Huntington's Disease predictive testing: clients' responses to reflective frames.
    Sarangi S; Bennert K; Howell L; Clarke A; Harper P; Gray J
    J Genet Couns; 2005 Feb; 14(1):29-42. PubMed ID: 15789154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular diagnosis of Huntington disease in Portugal: implications for genetic counselling and clinical practice.
    Costa MC; Magalhães P; Ferreirinha F; Guimarães L; Januário C; Gaspar I; Loureiro L; Vale J; Garrett C; Regateiro F; Magalhães M; Sousa A; Maciel P; Sequeiros J
    Eur J Hum Genet; 2003 Nov; 11(11):872-8. PubMed ID: 14571273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What do we tell the children? Contrasting the disclosure choices of two HD families regarding risk status and predictive genetic testing.
    Holt K
    J Genet Couns; 2006 Aug; 15(4):253-65. PubMed ID: 16850280
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Psychodynamic theory and counseling in predictive testing for Huntington's disease.
    Tassicker RJ
    J Genet Couns; 2005 Apr; 14(2):99-107. PubMed ID: 15959641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Huntington disease in 2013 - genetic choices across the life cycle.
    Morrison PJ
    Clin Genet; 2014 Jan; 85(1):76-7. PubMed ID: 23320517
    [No Abstract]   [Full Text] [Related]  

  • 72. Genetic prediction in Huntington's disease: what are the limitations imposed by pedigree structure?
    Misra VP; Baraitser M; Harding AE
    Mov Disord; 1988; 3(3):233-6. PubMed ID: 2973561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ethical issues in preclinical testing in Huntington disease: response to Margery Shaw's invited editorial comment.
    Hayden MR; Bloch M; Fox S; Crauford D
    Am J Med Genet; 1987 Nov; 28(3):761-3. PubMed ID: 2962495
    [No Abstract]   [Full Text] [Related]  

  • 74. [Multidisciplinary approach to counseling in Huntington's disease].
    Dangoor N; Gazit E; Sade M; Zimin B; Frydman M
    Harefuah; 1995 Jun; 128(12):751-4, 824. PubMed ID: 7557680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Diagnostic DNA testing for Huntington disease].
    Helle JR; Braathen GJ; Skodje T; Berg K
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2408-10. PubMed ID: 11475226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Two decades of Huntington disease testing: patient's demographics and reproductive choices.
    Krukenberg RC; Koller DL; Weaver DD; Dickerson JN; Quaid KA
    J Genet Couns; 2013 Oct; 22(5):643-53. PubMed ID: 23709094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of problems in making the reproductive decision after genetic counselling.
    Frets PG; Duivenvoorden HJ; Verhage F; Peters-Romeyn BM; Niermeijer MF
    J Med Genet; 1991 Mar; 28(3):194-200. PubMed ID: 2051456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington disease.
    Hawkins Virani AK; Creighton SM; Hayden MR
    Genet Med; 2013 Jun; 15(6):466-72. PubMed ID: 23222664
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What were you thinking?: individuals at risk for Huntington Disease talk about having children.
    Quaid KA; Swenson MM; Sims SL; Harrison JM; Moskowitz C; Stepanov N; Suter GW; Westphal BJ;
    J Genet Couns; 2010 Dec; 19(6):606-17. PubMed ID: 20734119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent.
    Bonnard A; Herson A; Gargiulo M; Durr A
    Eur J Hum Genet; 2019 Jan; 27(1):22-27. PubMed ID: 30206353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.